We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

000960:SZSEYunnan Tin Company Limited Analysis

Data as of 2026-03-07 - not real-time

CN¥40.30

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Yunnan Tin is trading firmly above its short‑ and long‑term moving averages, confirming a bullish technical backdrop. The MACD histogram remains positive, the RSI hovers around the neutral 50 mark and volume has been on an upward trajectory, all of which reinforce the current uptrend. However, the stock’s price is notably higher than the discounted cash‑flow fair value estimate, implying a material downside from a valuation perspective. The company delivers robust revenue growth and maintains a modest dividend payout with a low payout ratio, supporting dividend sustainability. Yet, margins are thin, the price‑to‑earnings multiple is elevated, and leverage measured by debt‑to‑equity is relatively high, tempering the upside narrative. Volatility over the past month has been pronounced, though the computed beta suggests limited systematic risk. In summary, while technical indicators are supportive, fundamental valuation signals caution, especially for longer horizons.
The sector—basic materials and mining—carries inherent commodity and regulatory sensitivities, and the firm’s exposure is concentrated in China, adding geographic considerations. Given the strong cash flow generation, the dividend appears sustainable, but the elevated valuation and high volatility warrant a measured stance. Investors should weigh the short‑term momentum against the longer‑term valuation gap before deciding on position sizing.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Price above multiple moving averages
  • Positive MACD histogram
  • Increasing trading volume

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong revenue growth but thin margins
  • Sustainable dividend payout
  • Valuation still above fair value

Long Term

> 3 years
Cautious
Model confidence: 5/10

Key Factors

  • Significant overvaluation relative to DCF
  • High price volatility
  • Elevated debt‑to‑equity ratio

Key Metrics & Analysis

Financial Health

Revenue Growth27.60%
Profit Margin4.04%
P/E Ratio36.0
ROE9.24%
ROA4.51%
Debt/Equity39.33
P/B Ratio3.3
Op. Cash FlowCN¥4.1B
Free Cash FlowCN¥1.5B

Technical Analysis

TrendBullish
RSI52.0
SupportCN¥32.80
ResistanceCN¥48.80
MA 20CN¥39.01
MA 50CN¥36.22
MA 200CN¥23.74
MACDBullish
VolumeIncreasing
Fear & Greed Index68.77

Valuation

Fair ValueCN¥30.46
Target PriceCN¥25.30
Upside/Downside-37.23%
GradeOvervalued
TypeGrowth
Dividend Yield0.74%

Risk Assessment

Beta0.14
Volatility91.33%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.